- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04831697
Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden (MCGR21)
Community-Based Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators propose to test the feasibility and preliminary efficacy of this multi-caregiving intervention on improving outcomes among AAW, ages 40-64 years with type 2 diabetes (T2DM) and multi-caregiving responsibilities using a pilot randomized design compared to diabetes enhanced usual care. The goals of the study will be assessed under the following specific aims:
Aim 1: To determine the feasibility of the multi-caregiving intervention as measured by recruitment, session attendance, retention, and treatment adherence in AAW with T2DM
Aim 2: To test the preliminary efficacy of the multi-caregiving intervention on glycemic and blood pressure control in AAW with T2DM compared to individual-delivered, health-educator led diabetes enhanced usual care at 6 months Hypothesis 1: AAW who receive the multi-caregiving intervention will have significant reductions in hemoglobin A1c at 6 months compared to AAW who receive diabetes enhanced usual care Hypothesis 2: AAW who receive the multi-caregiving intervention will have significant reductions in blood pressure at 6 months compared to AAW who receive diabetes enhanced usual care
Aim 3: To test the preliminary efficacy of the multi-caregiving intervention on self-care behaviors and quality of life in AAW with T2DM compared to individual-delivered, health educator led diabetes enhanced usual care at 6 months Hypothesis 1: AAW who receive the multi-caregiving intervention will have significant improvements in self-care behaviors (diet, physical activity, medication adherence, and blood glucose monitoring) at 6 months compared to AAW who receive diabetes enhanced usual care Hypothesis 2: AAW who receive the multi-caregiving intervention will have significant improvements in quality of life (SF-12 scores) at 6 months compared to AAW who receive diabetes enhanced usual care
In the final 6-month assessment, study participants will be asked to participate in 30 to 40-minute, semi-structured interviews by telephone. Findings will help refine the intervention and emphasize elements that enhance participant uptake and motivation for sustained behavior change for the future R01.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Joni Williams, MD, MPH
- Phone Number: 414-955-8827
- Email: jswilliams@mcw.edu
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Recruiting
- Medical College of Wisconsin
-
Contact:
- Joni Williams, MD, MPH
- Phone Number: 414-955-8827
- Email: jswilliams@mcw.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Age 40-64 years
- Self-identifies as female
- Self-identifies as African American or Non-Hispanic Black
- Self-reports multi-caregiving responsibilities
- Clinical diagnosis of T2DM based on HbA1c≥8% at the screening/baseline assessment
- Able to communicate in English
- Access to a telephone (i.e., landline, mobile device, smart device, etc.)
Exclusion criteria:
- Mental confusion at screening/baseline assessment suggesting significant dementia, active psychosis, or acute mental disorder
- Participation in other diabetes trials
- Life expectancy <6 months based on screening questionnaire
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multi-Caregiving Intervention
The multi-caregiving intervention consists of individual-based, social support, and health-educator facilitation and includes: a. Storytelling/sharing of experiences (5 minutes); social support and problem solving (15 minutes); Coping strategies (15minutes); and Structured Diabetes Education and Skills Training (15 minutes).
The final 5min will be used for debriefing/reviewing goals.
|
The multi-caregiving intervention consists of individual-based, social support, and health educator facilitation and includes: a. Storytelling/sharing of experiences (5 minutes); social support and problem solving (15 minutes); Coping strategies (15 minutes); and Structured Diabetes Education and Skills Training (15 minutes).
The last 5 minutes will be used to debrief and review goals.
|
Active Comparator: Diabetes Enhanced Usual Care Intervention
This is composed of individual-based, health educator-facilitated diabetes education and skills training and general health education and will receive structured diabetes education and skills training as described above (30 minutes) and an additional discussion on general health topics (i.e., back pain, dyspepsia, etc.) (30 minutes).
|
This is composed of individual-based, health educator-facilitated diabetes education and skills training and general health education and will receive structured diabetes education and skills training as described above (30 minutes) and an additional discussion on general health topics (i.e., back pain, dyspepsia, etc.) (30 minutes).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Glycemic Control from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Trained personnel will collect a blood specimen via finger stick (using a Point-of-Care device) or via venipuncture to collect 10cc of blood to measure HbA1c.
All collections will be performed in the community at a location convenient to the study participant.
At the screening visit, the HbA1c must be 8% or greater to be eligible for participation.
|
Screening/Baseline, 3-months, 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Diet from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Diet will be measured by the 26-item Dietary Screener Questionnaire (DSQ) used in the National Health and Nutrition Examination Survey.
Responses are used to estimate individual dietary intake for fruits, vegetables, dairy, added sugars, whole grains, fiber, adn calcium.
|
Screening/Baseline, 3-months, 6-months
|
Change in Physical Activity from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Physical activity will be measured using the 7-item International Physical Activity Questionnaire that asks about physical activities over the last 7 days.
|
Screening/Baseline, 3-months, 6-months
|
Change in Blood Pressure Control from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Blood pressure measurements will be obtained by the nurse/health educator using an automated BP monitor with participants seated comfortably for 5 minutes prior to the measurements.
|
Screening/Baseline, 3-months, 6-months
|
Change in Blood Glucose Monitoring from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Blood glucose monitoring will be assessed with the previously validated Summary of Diabetes Self-Care Activities (SDSCA) scale, where scores are calculated for each of the five areas assessed by the SDSCA over the past 7 days: diet, exercise, blood glucose monitoring, foot care, and smoking status.
Higher scores mean more engagement in self-care behaviors.
|
Screening/Baseline, 3-months, 6-months
|
Change in Medication Adherence from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
Medication adherence will be measured with the 6-item validated self-report Brooks Medication Adherence Scale.
Each question asks yes-no questions about adherence, where a "no" response indicates better adherence.
|
Screening/Baseline, 3-months, 6-months
|
Change in Health Related Quality of Life from Baseline to 6 months
Time Frame: Screening/Baseline, 3-months, 6-months
|
The SF-12 is a valid and reliable instrument to measure functional status and yields summary physical (PCS-12) and mental health (MCS-12) outcome scores.
Summary scores range from 0 to 100 where higher scores mean better quality of life.
|
Screening/Baseline, 3-months, 6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Joni Williams, MD, MPH, Medical College of Wisconsin
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21DK123720 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
-
University of Alabama at BirminghamUnited States Department of Defense; Loma Linda University; Brenda Davis Nutrition... and other collaboratorsCompletedType 2 Diabetes Mellitus
Clinical Trials on Multi-Caregiving Intervention
-
Boston Children's HospitalTulane University; Harvard University; University of Maryland, College Park; Inter-American... and other collaboratorsRecruitingPsychopathology | Brain Function | Socioemotional Development | Cognitive Ability | Behavioral and Neural Patterns of AttentionBrazil
-
University of PittsburghNational Institute of Mental Health (NIMH)Completed
-
University of UtahRecruiting
-
Eunice Kennedy Shriver National Institute of Child...CompletedChild Development DisordersRussian Federation
-
Amado David Quezada SánchezInstituto Nacional de Perinatologia Isidro Espinosa de los Reyes; Un Kilo de...Terminated
-
University Hospitals of Derby and Burton NHS Foundation...University of Hull; Sheffield Teaching Hospitals NHS Foundation Trust; University... and other collaboratorsRecruitingExercise | Breast Neoplasm FemaleUnited Kingdom
-
University of Alabama at BirminghamCompletedViolence in AdolescenceUnited States
-
Oslo University HospitalUniversity of Oslo; University of Bergen; Norwegian Centre for Ageing and Health and other collaboratorsCompletedQuality of Life | Pain | Dementia | Music | Activity, MotorNorway
-
University of MiamiNational Institute of Nursing Research (NINR)CompletedCaregivers of Alzheimer's Disease or Memory Problem PatientsUnited States
-
National Yang Ming UniversityNational Science and Technology CouncilCompletedAge-related Cognitive Decline | Age-related Physiology DeclineTaiwan